What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel.

Thienopyridines are a class of drug targeting the platelet adenosine diphosphate 2 receptor. They have been shown to significantly reduce platelet activity exerting an important role in those clinical settings in which such an effect is beneficial. Ticlopidine was first to be introduced several year...

Полное описание

Библиографические подробности
Главные авторы:	Testa, L, Bhindi, R, Van Gaal, W, Latini, R, Pizzocri, S, Lanotte, S, Biondi Zoccai, G, Valgimigli, M, Laudisa, M, Brambilla, N, Banning, A, Bedogni, F
Формат:	Journal article
Язык:	English
Опубликовано:	2010

Схожие документы

Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis.
по: Testa, L, и др.
Опубликовано: (2010)

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
по: L. Testa, и др.
Опубликовано: (2010-01-01)

Use of prasugrel in patients with clopidogrel hypersensitivity
по: Aparna Joshi, и др.
Опубликовано: (2022-01-01)

Interaction between statins and clopidogrel: is there anything clinically relevant?
по: Bhindi, R, и др.
Опубликовано: (2008)

Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition.
по: Testa, L, и др.
Опубликовано: (2009)

Differential impact of diabetes mellitus on antiplatelet effects of prasugrel and clopidogrel
по: Satoshi Niijima, и др.
Опубликовано: (2018-03-01)

Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
по: Dongwhane Lee, и др.
Опубликовано: (2018-09-01)

Clinical utility of remote platelet function measurement using P-selectin: assessment of aspirin, clopidogrel, and prasugrel and bleeding disorders
по: Philip M Bath, и др.
Опубликовано: (2018-07-01)

Platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor in comparison to clopidogrel: a retrospective pharmacodynamic analysis
по: Gerhard Selhorst, и др.
Опубликовано: (2019-04-01)

Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis.
по: Testa, L, и др.
Опубликовано: (2008)

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
по: Jan Kiebist, и др.
Опубликовано: (2021-09-01)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
по: Nicholas B Norgard, и др.
Опубликовано: (2009-10-01)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
по: Jim McLenachan, и др.
Опубликовано: (2019-05-01)

In silico Investigation on Clopidogrel, Prasugrel and Ticagrelor as Potential Mono Antiplatelet Therapy for Acute Coronary Syndrome
по: Muhammad Naufal Hibatullah, и др.
Опубликовано: (2024-11-01)

Effect of CYP2C19 status on platelet reactivity in Taiwanese acute coronary syndrome patients switching to prasugrel from clopidogrel: Switch Study
по: Feng-Yu Kuo, и др.
Опубликовано: (2022-09-01)

Prasugrel
по: Gianluca Airoldi, и др.
Опубликовано: (2013-04-01)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Опубликовано: (2019-07-01)

Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
по: Bartosz Olechowski, и др.
Опубликовано: (2016-01-01)

The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
по: Baoyi Guan, и др.
Опубликовано: (2022-01-01)

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment
по: Monica Verdoia, и др.
Опубликовано: (2019-10-01)

Study to assess improvement in therapeutic outcomes by platelet inhibition with prasugrel
по: Amit Madaan
Опубликовано: (2015-12-01)

Low-dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms: Follow-up of over 6 Months
по: Dongwhane Lee, и др.
Опубликовано: (2019-03-01)

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients.
по: Testa, L, и др.
Опубликовано: (2008)

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock
по: Vojko Kanic, и др.
Опубликовано: (2024-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
по: Yuri Kim, и др.
Опубликовано: (2023-01-01)

Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention.
по: Yuri Kim, и др.
Опубликовано: (2023-01-01)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
по: Gabriele Crimi, и др.
Опубликовано: (2019-01-01)

Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication
по: Constance C. F. M. J. Baaten, и др.
Опубликовано: (2015-09-01)

Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery.
по: Testa, L, и др.
Опубликовано: (2009)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
по: Shokoufeh Hajsadeghi, и др.
Опубликовано: (2016-01-01)

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
по: Shokoufeh Hajsadeghi, и др.
Опубликовано: (2016-08-01)

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS
по: P. S. LAGUTA, и др.
Опубликовано: (2017-12-01)

Legacy of blood: does prasugrel inhibit megakaryocytes and do juvenile platelets inherit this inhibition?
по: Carlos G. Santos-Gallego
Опубликовано: (2015-09-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
по: John I. Louca, и др.
Опубликовано: (2014-09-01)

The hurdles of translating a single-center observation into practice.
по: Testa, L, и др.
Опубликовано: (2008)

Digitalis: a dangerous drug in atrial fibrillation?
по: Testa, L, и др.
Опубликовано: (2008)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
по: Lulu Dai, и др.
Опубликовано: (2022-06-01)

Mortality in primary angioplasty patients starting antiplatelet therapy with prehospital prasugrel or clopidogrel: a 1-year follow-up from the European MULTIPRAC Registry
по: Goldstein P, и др.
Опубликовано: (2016-04-01)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
по: Zhe Wang, и др.
Опубликовано: (2020-03-01)

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis
по: Pravesh Kumar Bundhun, и др.
Опубликовано: (2018-05-01)